AIAS Cephalon

by Metamorphosis GmbH  · Based in Germany → — Powering AI-Assisted Surgery across orthopaedics and spine
Orthopedics Radiology
Website
Claim this tool
Is this the maker? Claim the company →

Regulatory Status Disclosed

Overview

AIAS Cephalon by Metamorphosis GmbH is an AI software tool designed to assist in processing radiological images automatically, helping clinicians analyze medical images more efficiently and accurately. It functions as a fully automated Software as a Medical Device (SaMD) that provides image analysis features and intraoperative instructions for proximal femur fracture surgery. The system supports the positioning of implants like the Depuy Synthes TFN-ADVANCED Proximal femoral nail (TFNA) implant by automatically detecting anatomy, implants, and tools in intraoperative X-ray images.

The software is indicated to assist in precisely positioning femur fracture implant components intraoperatively by measuring their positions relative to bone structures of interest. It is intended for adult patients and supports various surgical steps, including determining angles, finding entry points, nail insertion, and determining lengths of head elements and distal locking screws. AIAS Cephalon is not for primary image interpretation and is not for use on mobile phones.

Metamorphosis GmbH develops disruptive AI technologies for navigation and robotics in orthopaedic and spinal minimally invasive surgical procedures. Their approach uses AI-based, trackerless navigation that derives spatial intelligence from standard X-ray imaging without external optical tracking systems or reference frames, simplifying workflow and reducing operating room complexity.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Use Cases

  • Assisting in proximal femur fracture surgery
  • Intraoperative positioning of orthopedic implants
  • AI-assisted navigation in orthopaedic surgery
  • AI-assisted navigation in spinal surgery
  • Automated analysis of radiological images for surgical guidance

What Physicians Need to Know

FDA Clearance Pathway
510(k) cleared (K252214) on October 7, 2025, as 'Automated radiological image processing software' (Regulation Number: 892.2050, Product Code: QIH). It was found substantially equivalent to PhantomMSK Hip (K210136).
Supported Modalities
Primarily intraoperative X-ray (C-arm images) for proximal femur fracture surgery. The underlying neural networks were evaluated on Digitally Reconstructed Radiographs (DRRs) computed from CT scans.
AI Model Architecture
Utilizes deep neural networks. These models are static and do not evolve over time.
Reading Room Workflow Impact
Designed to assist in the intraoperative positioning of femur fracture implant components by providing image analysis features and instructions. Every new X-ray image triggers a new system response, aiming to simplify workflow and reduce operating room complexity. It is intended as an assistive tool, not for primary image interpretation.
Processing Speed (per study)
The underlying trackerless navigation platform calculates a 3D registration of anatomy, tools, and implants in less than 2 seconds for each 2D X-ray image.
DICOM Support & Standards
While not explicitly detailed for AIAS Cephalon, its function within a medical imaging workflow, particularly with X-ray images and potential integration with surgical systems, implies adherence to DICOM standards for image handling and exchange.
PACS Integration Method
Functions as image-processing software providing intraoperative instructions based on acquired X-ray images. The parent company emphasizes seamless integration with semi-automated and next-generation robotic systems, suggesting a robust integration method for image transfer and data exchange within the surgical environment, likely leveraging DICOM for image data.
Physician Tip

AIAS Cephalon is an intraoperative assistive tool for proximal femur fracture surgery, not a primary diagnostic interpretation tool. Clinicians should integrate its real-time image analysis and guidance for implant positioning while maintaining clinical judgment. Its rapid processing speed can enhance surgical efficiency. Be aware that the FDA clearance was not based on clinical performance data, so understanding its specific technical performance characteristics and limitations in your surgical context is crucial. The tool's ability to provide instant 3D registration from 2D X-rays can be a significant advantage in simplifying complex surgical navigation.

The system is designed for seamless integration with existing imaging equipment (C-arm X-ray) and is adaptable for semi-automated and next-generation robotic surgical systems. Its trackerless approach aims to reduce operating room complexity by eliminating the need for external optical tracking systems or reference frames. This suggests a focus on interoperability with surgical hardware and potentially surgical planning software, likely through standardized communication protocols.

Details

Category Radiology & Imaging AI, Surgical AI
Pricing Unknown — unknown
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

AIAS Cephalon received FDA 510(k) Premarket Notification clearance (K252214) on October 7, 2025. It was determined to be Substantially Equivalent (SESE) to a legally marketed device, indicated for assisting in the positioning of femur fracture implant components for adult patients.
Integrations
EHR Not specified
Specialties Orthopedics, Radiology

Ratings & Reviews

Rate AIAS Cephalon

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

metamorphosis.ai
AIAS Cephalon | FDA Radiology AI Device - X-ray Interpreter
AIAS Cephalon, developed by metamorphosis GmbH, is an AI software tool designed to automatically process radiological images, aiding clinicians in more efficient and accurate analysis of medical images.
2025-10
FDA
K252214 - 510(k) Premarket Notification - FDA
This FDA premarket notification details the submission and approval of AIAS Cephalon by Metamorphosis GmbH, classifying it under automated radiological image processing software.
2025-10
accessdata.fda.gov
October 7, 2025 metamorphosis GmbH Dr. Stefanie Horstmann Official Correspondent Technologiepark 9 Paderborn, NRW 33100 Germany - accessdata.fda.gov
This document from the FDA confirms the substantial equivalence of AIAS Cephalon to a predicate device, noting its fully automated software as a medical device (SaMD) for proximal femur fracture surgery.
2025-10
Rad AI Slice
Real-time AI boosts CT hemorrhage detection by 38% | Rad AI Slice
Rad AI Slice mentions AIAS Cephalon (metamorphosis GmbH) as an FDA-cleared AI software for automated radiology image processing, highlighting recent regulatory approvals in radiology AI.
2025-10
Nyquist AI Blog
Data Update: November 2025 - Nyquist AI Blog
Nyquist AI Blog includes AIAS Cephalon in its November 2025 data update, providing information on FDA device approvals and regulatory updates in the AI space.
2025-11
FDA
TPLC - Total Product Life Cycle - FDA
The FDA's Total Product Life Cycle database lists AIAS Cephalon by Metamorphosis GmbH as substantially equivalent, indicating its role in automated radiological image processing and analysis tools.
2026-07

Videos

Product demos, reviews, and walkthroughs for AIAS Cephalon.

Loading videos...

View all on YouTube

Frequently Asked Questions

AIAS Cephalon is an FDA-approved AI software tool developed by metamorphosis GmbH, designed to assist in the intraoperative positioning of femur fracture implant components for adult patients. It processes radiological images (C-arm images) to provide image analysis features and instructions, aiming to enhance the efficiency and accuracy of implant placement during surgery.
Yes, AIAS Cephalon received FDA approval on October 7, 2025, under the 510(k) premarket notification process. It is classified as a Class II medical device under Regulation Number 21 CFR 892.2050, for Medical Image Management and Processing Systems, with product code QIH.
AIAS Cephalon is designed to integrate seamlessly by deriving spatial intelligence from standard X-ray imaging without requiring external optical tracking systems or modified surgical instruments. It provides automated image analysis and intraoperative instructions based on C-arm images, supporting various surgical steps from determining angles to implant insertion and distal locking.
AIAS Cephalon is intended to assist, not replace, clinical judgment and experience; it is not for primary image interpretation. The device's effectiveness relies on identifiable points of interest in radiology images, and potential software or use errors could lead to prolonged surgery or the need for re-takes.
AIAS Cephalon utilizes intraoperative X-ray images to detect anatomy, implants, and tools for its analysis and instructions. While the search results do not detail specific patient data privacy protocols for AIAS Cephalon, medical devices in the EU, including AI-driven solutions, must comply with stringent regulations like the Medical Devices Regulation (MDR) and potentially the AI Act, which include requirements for data governance and post-market monitoring.
While the search results specifically detail AIAS Cephalon for femur fracture implant positioning, the broader field of AI in healthcare includes other solutions for surgical intelligence across orthopedics and spine, as well as AI-powered imaging analysis tools. metamorphosis GmbH itself focuses on AI-assisted surgery across orthopaedics and spine, suggesting a competitive landscape with various AI-driven navigation and imaging solutions.
The provided search results do not contain specific information regarding the pricing model or cost associated with implementing AIAS Cephalon. Pricing for medical AI solutions typically varies based on licensing, integration, support, and the specific healthcare system's needs.

Related Tools

ScreenPoint Medical
ScreenPoint Medical
Clinical Decision Support & Reference
ScreenPoint Medical offers Transpara, an AI-powered solution for breast cancer detection and diagnosis in mammography and digital breast tomosynthesis, designed to assist radiologists.
Microsoft Azure AI (with BAA)
Microsoft Azure AI
Clinical Decision Support & Reference
Microsoft Azure AI offers a secure, HIPAA-compliant platform with BAA support for developing and deploying AI solutions across the healthcare industry, from clinical decision support to research.
Varied, with pay-as-you-go and commitment pricing options.
Google Cloud AI (with BAA)
Google
Clinical Decision Support & Reference
Google Cloud AI provides a powerful suite of machine learning and AI tools developed to help healthcare businesses optimize operations, gain insights from data, and enhance patient care. It offers solutions for improved diagnostics, personalized treatment, workflow automation, and cost optimization, all built on a secure and compliant platform.
Paid
AI Orchestrator
GE HealthCare
Practice Management & Scheduling
GE HealthCare's AI Orchestrator integrates and manages AI applications within a healthcare imaging ecosystem to streamline workflows and improve diagnostic accuracy.
Contact for pricing
AI-enabled Ultrasound Technology (licensed to Butterfly Network)
Butterfly Network
Clinical Decision Support & Reference
An FDA-cleared AI-enabled ultrasound technology that estimates fetal gestational age from standardized 'blind sweep' ultrasound videos, expanding access to essential obstetric care.
Starts at $2,699 for the handheld probe, plus a required membership subscription.
4DMedical (Imbio)
4DMedical
Cardiology AI
4DMedical, with its acquisition of Imbio, offers a comprehensive suite of AI-driven medical imaging solutions for chronic lung and cardiothoracic diseases, providing quantitative and personalized insights from X-ray and CT scans.

See all Radiology & Imaging AI tools →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.